Search - tctmd.com

Displaying 1 - 20 of 73

Sort: Relevancy | Date

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation TCT 2016

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

November 01, 2016

Presentation TCT 2016

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella

November 01, 2016

Presentation TCT 2016

Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry

Presenter: Fernando Alfonso, Ran Kornowski, Bernardo Cortese

November 01, 2016

Presentation TCT 2016

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla

October 30, 2016

Presentation TCT 2016

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman

October 30, 2016

Presentation TCT 2016

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Presenter: Fernando Alfonso, Stephan Windecker

October 30, 2016

Presentation TCT 2016

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis

Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong

October 30, 2016

Presentation TCT 2016

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini

October 30, 2016

Presentation TCT 2016

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns

October 30, 2016

Presentation TCT 2016

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi

October 30, 2016

Presentation TCT 2016

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee

October 30, 2016

Presentation TCT 2016

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz

October 30, 2016

Presentation TCT 2016

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara

October 30, 2016

Presentation TCT 2016

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Presenter: Fernando Alfonso, Stephan Windecker, Yasunori Ueda

October 30, 2016

Presentation TCT 2016

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Presenter: Fernando Alfonso, Stephan Windecker, Elazer R. Edelman

October 30, 2016

Presentation TCT 2016

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Presenter: Fernando Alfonso, Stephan Windecker, Juan F. Granada

October 30, 2016

Presentation TCT 2016

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Presenter: Fernando Alfonso, Stephan Windecker, Aloke V. Finn

October 30, 2016

Presentation TCT 2016

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Presenter: Fernando Alfonso, Stephan Windecker, Mahesh V Madhavan

October 30, 2016

Presentation TCT 2016

Treatment of In-Stent Restenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Advertisement

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Treatment of In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content